EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

MDMA ‐assisted psychotherapy for the treatment of PTSD : A systematic review and meta‐analysis of randomized controlled trials ( RCTs )

Ghada Shahrour, Kainat Sohail, Safa Elrais, Muhammad Hamza Khan iD, Javeria Javeid, Khubaib Samdani, Hajra Mansoor, Syed Izhar Hussain, Dhruvikumari Sharma, Muhammad Ehsan, Abdulqadir J Nashwan iD

Neuropsychopharmacology Reports · 2024-12 · 44 (4) · 672-681

DOI: 10.1002/npr2.12485 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Neuropsychopharmacology Reports, online erschienen am 09.10.2024. Verfasst von Ghada Shahrour und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Community and Mental Health Nursing, Faculty of Nursing, Jordan University of Science and Technology, Irbid, Jordan. Hauptthemen laut MEDLINE: Stress Disorders, Post-Traumatic, N-Methyl-3,4-methylenedioxyamphetamine, Randomized Controlled Trials as Topic, Psychotherapy. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Post‐traumatic stress disorder (PTSD) is a mental health disorder resulting from exposure to traumatic events, manifesting in various debilitating symptoms. Despite available treatments, many individuals experience inadequate response or significant side effects. Previous reviews suggest promising outcomes with MDMA‐assisted psychotherapy (MDMA‐AT), but limitations prompt the need for a comprehensive evaluation.

Methods

We searched various online databases and registries such as MEDLINE (via PubMed), Embase, the Cochrane Central Register of Controlled Trials (CENTRAL), and ClinicalTrials.gov to retrieve RCTs that fit our inclusion criteria. We performed meta‐analyses using Review Manager by applying a random‐effects model. Dichotomous and continuous outcomes were pooled as risk ratios (RR) and standard mean difference (SMD), respectively.

Results

Nine studies with a total of 297 participants with PTSD were included in our meta‐analysis. The control group consisted of inactive doses of MDMA (25–40 mg) or placebo. Our meta‐analysis showed that MDMA‐AT led to a significant reduction in the Clinician‐Administered PTSD Scale for DSM‐5 (CAPS‐5) severity scores as compared to the control group (SMD −1.10, 95% CI: −1.62 to −0.59). More patients in the MDMA‐AT group exhibited significant response (RR 1.59, 95% CI: 1.22, 2.08) and remission (RR 2.32, 95% CI: 1.47 to 3.66) as compared to patients in the control group. There was no significant difference regarding the incidence of ≥1 treatment‐emergent adverse events (TEAE), ≥1 severe TEAE, and suicidal ideation between the two groups.

Conclusion

MDMA‐AT demonstrates significant efficacy in improving PTSD symptoms, enhancing both response and remission rates in individuals with chronic, treatment‐resistant PTSD, while maintaining a favorable safety profile.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stress Disorders, Post-TraumaticN-Methyl-3,4-methylenedioxyamphetamineRandomized Controlled Trials as TopicPsychotherapyHumansCombined Modality TherapyTreatment Outcome

Stichwörter der Autor:innen

MDMA‐ATRCTsmeta‐analysispost‐traumatic stress disorder

Substanzen

N-Methyl-3,4-methylenedioxyamphetamine

Autor:innen und Institutionen

  • Department of Community and Mental Health Nursing, Faculty of Nursing, Jordan University of Science and Technology, Irbid, Jordan.
  • College of Nursing, RAK Medical and Health Sciences University, Ras Al-Khaimah.
  • Department of Psychiatry, Jinnah Sindh Medical University, Karachi, Pakistan.
  • Department of Psychiatry, University of Tripoli, Tripoli, Libya.
  • Department of Psychiatry, Karachi Medical and Dental College, Karachi, Pakistan.
  • Department of Psychiatry, Allama Iqbal Medical College, Lahore, Pakistan.

ORCID-Profile: Muhammad Hamza Khan, Abdulqadir J Nashwan

Zitieren

APA

Shahrour, G., Sohail, K., Elrais, S., Khan, M. H., Javeid, J., Samdani, K., Mansoor, H., Hussain, S. I., Sharma, D., Ehsan, M., & Nashwan, A. J. (2024). MDMA ‐assisted psychotherapy for the treatment of PTSD : A systematic review and meta‐analysis of randomized controlled trials ( RCTs ). Neuropsychopharmacology Reports, 44(4), 672-681. https://doi.org/10.1002/npr2.12485

Vancouver

Shahrour G, Sohail K, Elrais S, Khan MH, Javeid J, Samdani K, et al. MDMA ‐assisted psychotherapy for the treatment of PTSD : A systematic review and meta‐analysis of randomized controlled trials ( RCTs ). Neuropsychopharmacology Reports. 2024;44(4):672-681. doi:10.1002/npr2.12485

BibTeX
@article{Shahrour2024,
  author = {Shahrour, Ghada and Sohail, Kainat and Elrais, Safa and Khan, Muhammad Hamza and Javeid, Javeria and Samdani, Khubaib and Mansoor, Hajra and Hussain, Syed Izhar and Sharma, Dhruvikumari and Ehsan, Muhammad and Nashwan, Abdulqadir J},
  title = {MDMA ‐assisted psychotherapy for the treatment of PTSD : A systematic review and meta‐analysis of randomized controlled trials ( RCTs )},
  journal = {Neuropsychopharmacology Reports},
  year = {2024},
  volume = {44},
  number = {4},
  pages = {672--681},
  doi = {10.1002/npr2.12485}
}
Kostenlos starten →